UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Corrigendum to “Disease burden and unmet need for acute allergic reactions – A patient perspective” [World Allergy Organ J 17(4) (2024 Apr) 100896]

The World Allergy Organization journal, 2024-10, Vol.17 (10), p.100973, Article 100973

2024

Volltextzugriff (PDF)

Treatment Preferences for Acute Allergic Reactions: A Discrete Choice Experiment

Journal of health economics and outcomes research (Online), 2024, Vol.11 (1), p.157-165

2024

Volltextzugriff (PDF)

The Potential Cost and Cost-Effectiveness Impact of Using a Machine Learning Algorithm for Early Detection of Sepsis in Intensive Care Units in Sweden

Journal of health economics and outcomes research (Online), 2022-01, Vol.9 (1), p.101-110

2022

Volltextzugriff (PDF)

Disease burden and unmet need for acute allergic reactions – A patient perspective

The World Allergy Organization journal, 2024-04, Vol.17 (4), p.100896, Article 100896

2024

Volltextzugriff (PDF)

JAK2 V617F as a Marker for Long-Term Disease Progression and Mortality in Polycythemia Vera and its Role in Economic Modeling

Journal of health economics and outcomes research (Online), 2020, Vol.7 (1), p.61-70

2020

Volltextzugriff (PDF)

Cost-Effectiveness of Vaccination of Older Adults with an MF59 ® -Adjuvanted Quadrivalent Influenza Vaccine Compared to Standard-Dose and High-Dose Vaccines in Denmark, Norway, and Sweden

Vaccines (Basel), 2023-03, Vol.11 (4), p.753

2023

Volltextzugriff (PDF)

Annual costs of treatment for venous leg ulcers in Sweden and the United Kingdom

Wound repair and regeneration, 2005-01, Vol.13 (1), p.13-18

2005

Volltextzugriff (PDF)

Health economic modeling of the potential cost saving effects of Neurally Adjusted Ventilator Assist

Therapeutic advances in respiratory disease, 2016-02, Vol.10 (1), p.3-17

2016

Volltextzugriff (PDF)

Economic Analysis of Panitumumab Compared With Cetuximab in Patients With Wild-Type KRAS Metastatic Colorectal Cancer That Progressed After Standard Chemotherapy

Clinical therapeutics, 2016-06, Vol.38 (6), p.1376-1391

2016

Volltextzugriff (PDF)

Corrigendum to "Disease burden and unmet need for acute allergic reactions - A patient perspective" World Allergy Organ J 17(4) (2024 Apr) 100896

The World Allergy Organization journal, 2024-10, Vol.17 (10), p.100973

2024

Volltextzugriff (PDF)

The Potential Cost and Cost-Effectiveness Impact of Using a Machine Learning Algorithm for Early Detection of Sepsis in Intensive Care Units in Sweden

Journal of health economics and outcomes research (Online), 2022-04

2022

Volltextzugriff (PDF)

Cost-effectiveness analysis of panitumumab plus mFOLFOX6 compared with bevacizumab plus mFOLFOX6 for first-line treatment of patients with wild-type RAS metastatic colorectal cancer

European journal of cancer (1990), 2014-11, Vol.50 (16), p.2791-2801

2014

Volltextzugriff (PDF)

Population preferences and choice of primary care models: A discrete choice experiment in Sweden

Health policy (Amsterdam), 2007-10, Vol.83 (2), p.314-322

2007

Volltextzugriff (PDF)

Health Economic Guidelines—Similarities, Differences and Some Implications

Value in health, 2001-05, Vol.4 (3), p.225-250

2001

Volltextzugriff (PDF)

Cost Effectiveness of Darunavir/Ritonavir 600/100mg bid in Treatment-Experienced, Lopinavir-Naive, Protease Inhibitor-Resistant, HIV-Infected Adults in Belgium, Italy, Sweden and the UK

PharmacoEconomics, 2010-12, Vol.28 (Suppl 1), p.147-167

2010

Volltextzugriff (PDF)

Patient preferences and willingness-to-pay for ADHD treatment with stimulants using discrete choice experiment (DCE) in Sweden, Denmark and Norway

Nordic journal of psychiatry, 2013-10, Vol.67 (5), p.351-359

2013

Volltextzugriff (PDF)

Cost Effectiveness of Darunavir/Ritonavir 600/100 mg bid in Treatment-Experienced, Lopinavir-Naive, Protease Inhibitor-Resistant, HIV-Infected Adults in Belgium, Italy, Sweden and the UK

PharmacoEconomics, 2010-01, Vol.28 (1), p.147-167

2010

Volltextzugriff (PDF)

Are Treatment Satisfaction, Quality of Life, and Self-assessed Disease Severity Relevant Parameters for Patient Registries? Experiences from Finnish and Swedish Patients with Psoriasis

Acta dermato-venereologica, 2011-06, Vol.91 (4), p.409-414

2011

Volltextzugriff (PDF)

Cost-minimization analysis of panitumumab compared with cetuximab for first-line treatment of patients with wild-type RAS metastatic colorectal cancer

Journal of medical economics, 2015-01, Vol.18 (8), p.619-628

2015

Volltextzugriff (PDF)

Original Research Articles - Clinical Science: Annual costs of treatment for venous leg ulcers in Sweden and the United Kingdom

Wound repair and regeneration, 2005-01, Vol.13 (1), p.13-18

2005

Volltextzugriff (PDF)

Population preferences and choice of primary care models: A discrete choice experiment in Sweden

Health policy (Amsterdam), 2007, Vol.82, p.314

2007

Volltextzugriff (PDF)

Estimating the value of novel interventions for Parkinson's disease: An early decision-making model with application to dopamine cell replacement

Parkinsonism & related disorders, 2006-10, Vol.12 (7), p.443-452

2006

Volltextzugriff (PDF)

Implementing competition in the pharmacy sector: lessons from Iceland and Norway

Applied health economics and health policy, 2002, Vol.1 (3), p.149-156

2002

Volltextzugriff (PDF)

Health services need knowledge of how the public values health

Läkartidningen, 2003-10, Vol.100 (43), p.3436-3437

2003

Volltextzugriff (PDF)

Svag studie om primärvårdspreferenser

Läkartidningen, 2006-09, Vol.103 (38), p.2759

2006

Volltextzugriff (PDF)

1 – 25 von 38

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(36)
Mit Volltextzugriff
(33)

Publikationsform

Artikel
(38)

Sprache

Englisch
(33)
Schwedisch
(5)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Corrigendum to “Disease burden and unmet need for acute allergic reactions – A patient perspective” [World Allergy Organ J 17(4) (2024 Apr) 100896]

Treatment Preferences for Acute Allergic Reactions: A Discrete Choice Experiment

The Potential Cost and Cost-Effectiveness Impact of Using a Machine Learning Algorithm for Early Detection of Sepsis in Intensive Care Units in Sweden

Disease burden and unmet need for acute allergic reactions – A patient perspective

JAK2 V617F as a Marker for Long-Term Disease Progression and Mortality in Polycythemia Vera and its Role in Economic Modeling

Cost-Effectiveness of Vaccination of Older Adults with an MF59 ® -Adjuvanted Quadrivalent Influenza Vaccine Compared to Standard-Dose and High-Dose Vaccines in Denmark, Norway, and Sweden

Annual costs of treatment for venous leg ulcers in Sweden and the United Kingdom

Health economic modeling of the potential cost saving effects of Neurally Adjusted Ventilator Assist

Economic Analysis of Panitumumab Compared With Cetuximab in Patients With Wild-Type KRAS Metastatic Colorectal Cancer That Progressed After Standard Chemotherapy

Corrigendum to "Disease burden and unmet need for acute allergic reactions - A patient perspective" World Allergy Organ J 17(4) (2024 Apr) 100896

The Potential Cost and Cost-Effectiveness Impact of Using a Machine Learning Algorithm for Early Detection of Sepsis in Intensive Care Units in Sweden

Cost-effectiveness analysis of panitumumab plus mFOLFOX6 compared with bevacizumab plus mFOLFOX6 for first-line treatment of patients with wild-type RAS metastatic colorectal cancer

Population preferences and choice of primary care models: A discrete choice experiment in Sweden

Health Economic Guidelines—Similarities, Differences and Some Implications

Cost Effectiveness of Darunavir/Ritonavir 600/100mg bid in Treatment-Experienced, Lopinavir-Naive, Protease Inhibitor-Resistant, HIV-Infected Adults in Belgium, Italy, Sweden and the UK

Patient preferences and willingness-to-pay for ADHD treatment with stimulants using discrete choice experiment (DCE) in Sweden, Denmark and Norway

Cost Effectiveness of Darunavir/Ritonavir 600/100 mg bid in Treatment-Experienced, Lopinavir-Naive, Protease Inhibitor-Resistant, HIV-Infected Adults in Belgium, Italy, Sweden and the UK

Are Treatment Satisfaction, Quality of Life, and Self-assessed Disease Severity Relevant Parameters for Patient Registries? Experiences from Finnish and Swedish Patients with Psoriasis

Cost-minimization analysis of panitumumab compared with cetuximab for first-line treatment of patients with wild-type RAS metastatic colorectal cancer

Original Research Articles - Clinical Science: Annual costs of treatment for venous leg ulcers in Sweden and the United Kingdom

Population preferences and choice of primary care models: A discrete choice experiment in Sweden

Estimating the value of novel interventions for Parkinson's disease: An early decision-making model with application to dopamine cell replacement

Implementing competition in the pharmacy sector: lessons from Iceland and Norway

Health services need knowledge of how the public values health

Svag studie om primärvårdspreferenser

Suchergebnisse filtern